Go Pro
OTCMKTS:MLCPF

Medipharm Labs (MLCPF) Stock Price, News & Analysis

$0.05 +0.00 (+0.73%)
As of 08/14/2026

About Medipharm Labs Stock (OTCMKTS:MLCPF)

Advanced

Key Stats

Today's Range
$0.05
$0.05
50-Day Range
$0.05
$0.06
52-Week Range
$2.57
$2.57
Volume
109,380 shs
Average Volume
181,345 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medipharm Labs Corp. is a Canadian contract development and manufacturing organization (CDMO) specializing in pharmaceutical-grade cannabis formulations. The company partners with licensed producers and brand owners to deliver science-based product development, formulation and manufacturing services across a variety of dosage forms.

Its capabilities include the design and production of oils, capsules, tablets, soft gels, topical creams and vape cartridges, leveraging proprietary formulation technologies such as nanoemulsions and controlled-release systems. Medipharm Labs operates a fully integrated, Good Manufacturing Practice (GMP) certified facility, offering analytical testing, stability studies and scale-up support from pilot to commercial volumes.

Headquartered in Laval, Quebec, Medipharm Labs serves clients in Canada and select international markets where cannabis derivatives are permitted. The company’s facility infrastructure and analytical laboratories enable compliance with regulatory requirements in multiple jurisdictions, supporting both medical and adult-use applications.

Founded in the mid-2010s, Medipharm Labs has built a portfolio of patented cannabis formulation technologies and matured its service offering under the leadership of Chief Executive Officer David Stewart. The management team draws on pharmaceutical industry experience to drive innovation in cannabinoid product development and to scale manufacturing operations in response to evolving market demand.

AI Generated. May Contain Errors.

Receive MLCPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medipharm Labs and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MLCPF Stock News Headlines

Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel
Q2 2025 Medipharm Labs Corp Earnings Call Transcript
LABS:CA MediPharm Labs Corp.
MediPharm Labs Shows Strong Q3 Growth
See More Headlines

MLCPF Stock Analysis - Frequently Asked Questions

Medipharm Labs' stock was trading at $0.0540 on January 1st, 2026. Since then, MLCPF shares have increased by 1.7% and is now trading at $0.0549.

Shares of MLCPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:MLCPF
CIK
N/A
Fax
N/A
Employees
28
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (OTCMKTS:MLCPF) was last updated on 8/17/2026 by MarketBeat.com Staff.
From Our Partners